Page breadcrumb nav

VAERS Report 2156705

Case Report Section

Détails du rapport Vaer

Âge: N/A

Genre: Male

Région : Outside US

Patient décédé?
Non
Renseignements sur les vaccins

Nom: COVID19 (COVID19 (PFIZER-BIONTECH))

Type : Coronavirus 2019 vaccine

Fabricant: PFIZER

Lot: unknown


Date de réception du rapport
2022-03-04
Date à laquelle le formulaire est complèté
Date de vaccination
2022-02-13
Date d’apparition
1
Nombre de jours (date d’apparition – date de vaccination)
1
Description de l’événement indésirable

patient received dose 4; patient received dose 4; shortness of breath; reducing vision; near fainting/felt faint; near fainting/felt faint; this is a spontaneous report received from a contactable reporter(s) (consumer or other non hcp) from the regulatory agency (ra). the reporter is the patient. regulatory number: gb-mhra-webcovid-202202141211210020-tgxfo (ra). other case identifier(s): gb-mhra-adr 26601177 (ra). a 40 year-old male patient received bnt162b2 (comirnaty), administration date 13feb2022 (batch/lot number: unknown) as dose 4 (booster), single for covid-19 immunisation. the patient's relevant medical history was not reported. there were no concomitant medications. vaccination history included: covid-19 vaccine (dose 1; manufactuerer unknown), for covid-19 immunisation; covid-19 vaccine (dose 2; manufactuerer unknown), for covid-19 immunisation; covid-19 vaccine (dose 3; manufactuerer unknown), for covid-19 immunisation. patient has not had symptoms associated with covid-19. the following information was reported: immunisation (medically significant), off label use (medically significant), outcome "unknown" and all described as "patient received dose 4"; dyspnoea (medically significant), outcome "unknown", described as "shortness of breath"; presyncope (medically significant), dizziness (medically significant) all with onset 14feb2022, outcome "recovered" (14feb2022) and all described as "near fainting/felt faint"; visual impairment (medically significant), outcome "unknown", described as "reducing vision". clinical course: patient felt faint with shortness of breath and reducing vision. this worsened for aprx. 1 - 2 mins, i managed to splash some cold water on face and get to bed to lie down. after this, the condition eased over the next 2 - 3 mins. no follow-up attempts are possible; information about lot/batch number cannot be obtained. no further information is expected

Données de laboratoire
na
Liste des symptômes
dizziness dyspnoea immunisation presyncope visual impairment off label use
Patient décédé?
Non
Date de décès
N/A
Anomalie congénitale
false
Vaccin administré par :
Other
Vaccin acheté par :
Inconnu
Visite d’un patient à l’urgence?
Non
Patient hospitalisé?
Non
Séjour à l’hôpital
Non
Nombre de jours à l’hôpital
Non spécifié
Invalidité permanente?
Non
Allergies:
na
Maladie actuelle
na